NATCO PHARMA (CANADA) INC — Oseltamivir Importer Profile
Pharmaceutical Importer · #2 buyer for Oseltamivir · $400.0K import value · 8 shipments · CANADA · DGFT Verified
NATCO PHARMA (CANADA) INC is the #2 importer of Oseltamivir from India with $400.0K in import value and 8 verified shipments. NATCO PHARMA (CANADA) INC holds a 2.4% market share in Oseltamivir imports based in CANADA. The company sources from 1 verified supplier across 8 formulations shipped to 1 country. Overall, NATCO PHARMA (CANADA) INC imports 2 pharmaceutical products worth $3.8M across 2 therapeutic categories.
NATCO PHARMA (CANADA) INC — Oseltamivir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Oseltamivir to NATCO PHARMA (CANADA) INC?
Verified from 8 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NATCO PHARMA LIMITED | $400.0K | 8 | 100.0% |
NATCO PHARMA (CANADA) INC sources Oseltamivir from 1 verified Indian supplier based on 8 customs records. The primary supplier is NATCO PHARMA LIMITED accounting for 100.0% of imports.
How Does NATCO PHARMA (CANADA) INC Compare to Nearest Oseltamivir Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $4.4M | 88 | $50.0K |
| 2 | NATCO PHARMA (CANADA) INC ★ | CANADA | $3.0M | 59 | $50.0K |
| 4 | AMNEAL PHARMACEUTICALS, LLC (KY) | UNITED STATES | $2.4M | 47 | $50.0K |
| 3 | STRIDES PHARMA INC | UNITED STATES | $1.6M | 33 | $50.0K |
NATCO PHARMA (CANADA) INC ranks #2 among 314 Oseltamivir importers from India. Average shipment value of $50.0K compared to the market average of $57.8K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES and AMNEAL PHARMACEUTICALS, LLC (KY).
Where Does NATCO PHARMA (CANADA) INC Import Oseltamivir To?
Destination countries from 8 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $400.0K | 8 | 100.0% |
NATCO PHARMA (CANADA) INC imports Oseltamivir to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $400.0K.
What Oseltamivir Formulations Does NATCO PHARMA (CANADA) INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| NAT OSELTAMIVIR PHOSPHATE 75MG CAPSULES10 S APPENDIX 4R RODTEP ENTRY NO 10153 OTHER REFERENCE S CI NO 122278 | $50.0K | 1 |
| NAT OSELTAMIVIR PHOSPHATE 30MG CAPSULES10 S APPENDIX 4R RODTEP ENTRY NO 10153 OTHER REFERENCE S CI NO 122280 | $50.0K | 1 |
| NAT-OSELTAMIVIR 45MG CAPSULES 10'S 45792X10'SAPPENDIX 4R RODTEP ENTRY NO:10153OTHER REFERENCES CI NO: 123080 | $50.0K | 1 |
| NAT-OSELTAMIVIR 75MG CAPSULES 10'S 94752X10'SAPPENDIX 4R RODTEP ENTRY NO:10153OTHER REFERENCES CI NO: 123078 | $50.0K | 1 |
| NAT-OSELTAMIVIR 75MG CAPSULES 10'S 94464X10'SAPPENDIX 4R RODTEP ENTRY NO:10153OTHER REFERENCES CI NO: 123079 | $50.0K | 1 |
| NAT-OSELTAMIVIR 75MG CAPSULES 10'S 82848X10'SAPPENDIX 4R RODTEP ENTRY NO:10153OTHER REFERENCES CI NO: 123085 | $50.0K | 1 |
| NAT-OSELTAMIVIR 75MG CAPSULES 10'S 8208 | $50.0K | 1 |
| NAT-OSELTAMIVIR 75MG CAPSULES 10'S 83232X10'SAPPENDIX 4R RODTEP ENTRY NO:10153OTHER REFERENCES CI NO: 123089 | $50.0K | 1 |
NATCO PHARMA (CANADA) INC imports 8 distinct Oseltamivir formulations from India. The top formulation is NAT OSELTAMIVIR PHOSPHATE 75MG CAPSULES10 S APPENDIX 4R RODT with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Oseltamivir into Canada
What NATCO PHARMA (CANADA) INC and other importers must comply with to import Oseltamivir from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Oseltamivir
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Oseltamivir from India and How Much Does NATCO PHARMA (CANADA) INC Import?
India exported $18.1M worth of Oseltamivir through 2,149 shipments from 118 suppliers to 79 countries, serving 314 buyers globally. NATCO PHARMA (CANADA) INC imports $400.0K of this total, accounting for 2.4% of India's Oseltamivir exports with 8 shipments from CANADA. This is verified from 8 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for NATCO PHARMA (CANADA) INC's Oseltamivir Imports?
NATCO PHARMA (CANADA) INC's average Oseltamivir order value is $50.0K per consignment, based on 8 shipments totaling $400.0K. NATCO PHARMA (CANADA) INC is based in CANADA and ranks #2 among all Oseltamivir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Oseltamivir to NATCO PHARMA (CANADA) INC?
NATCO PHARMA (CANADA) INC sources Oseltamivir from 1 verified Indian supplier: NATCO PHARMA LIMITED ($400.0K, 100.0%). This is based on 8 customs records.
How Does NATCO PHARMA (CANADA) INC Compare to Other Oseltamivir Importers?
NATCO PHARMA (CANADA) INC ranks #2 among 314 Oseltamivir importers from India with a 2.4% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($4.4M), NATCO PHARMA (CANADA) INC ($3.0M), AMNEAL PHARMACEUTICALS, LLC (KY) ($2.4M). NATCO PHARMA (CANADA) INC processed 8 shipments from CANADA.
About NATCO PHARMA (CANADA) INC
NATCO PHARMA (CANADA) INC imports 2 products worth $3.8M. Beyond Oseltamivir, top products include Pomalidomide. View the complete NATCO PHARMA (CANADA) INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oseltamivir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oseltamivir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NATCO PHARMA (CANADA) INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NATCO PHARMA (CANADA) INC's capped import value divided by total capped export value for Oseltamivir across all Indian exporters.
- 5.Verified Records: This page is backed by 8 individual customs records matching NATCO PHARMA (CANADA) INC importing Oseltamivir, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 79+ countries, 314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oseltamivir Import Data for NATCO PHARMA (CANADA) INC
Access order-level details, pricing data, supplier connections, and competitive analysis for NATCO PHARMA (CANADA) INC's Oseltamivir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NATCO PHARMA (CANADA) INC
Full Company Profile →
2 products · $3.8M total trade · 2 categories
NATCO PHARMA (CANADA) INC × Oseltamivir
Verified from customs records
Company Overview
Top Products by NATCO PHARMA (CANADA) INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NATCO PHARMA (CANADA) INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oseltamivir. For current order-level data, contact TransData Nexus.